本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PHAXIAM THERAPEUTICS S A SPON ADR EACH REPR 1 ORD

3.10
+0.0000
成交量:- -
成交额:- -
市值:1,883.22万
市盈率:-1.48
高:3.10
开:3.10
低:3.10
收:3.10
数据加载中...
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/01

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2023/03/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/12/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/06/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2022/04/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]